Form 10-Q Pulse Biosciences, Inc. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
- Marvell agrees to acquire Lumentum in all-stock deal valued at $115B
- Cipher Digital posts Q3 revenue of $27M, logs first HPC lease income
- Binance sees spike in withdrawals as exchange returns online after $6.3 billion heist
- Oracle files to offer $10B in common stock alongside senior notes
- Marvell to buy Lumentum in $115 billion deal in AI data-center bet
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Pulse Biosciences (PLSE) PT Lowered to $43 at H.C. Wainwright
November 16, 2021 6:38 AM ESTH.C. Wainwright analyst Swayampakula Ramakanth lowered the price target on Pulse Biosciences (NASDAQ: PLSE) to $43.00 (from $46.00) while maintaining a Buy rating.
The analyst commented, "Pulse reported 3Q21 financial results and held a conference call on November 15. During the quarter, while Pulse is... More
Pulse Biosciences, Inc. (PLSE) Tops Q3 EPS by 5c
November 15, 2021 5:05 PM ESTPulse Biosciences, Inc. (NASDAQ: PLSE) reported Q3 EPS of ($0.48), $0.05 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $574 thousand versus the consensus estimate of $190 thousand.
For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.
... More


